CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- ScaleMarket cap is $1.18B, above the global median of $1.15B
- FinancialsAltman Z-Score 5.61: safe zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.30%Below 5Y avg (1.50%)
Annual Rate
CNY 0.22Paid annual
Payout Ratio
72.7%Moderate
Payback Period
79.1 yr
Last Ex-Dividend
Jun 2, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
7.94BCNY1.18B · vs all stocks (USD)
Revenue (TTM)
1.87BCNY277.48M · vs all stocks (USD)
Profit Margin
-8.98%vs Medical Devices peers
Beta
0.8280xvs all stocks
52-Week Change
-26.25%vs all stocks
Market Capitalization
7.94BCNY1.18B · vs all stocks (USD)
Enterprise Value
6.87BCNY1.02B · vs all stocks (USD)
Forward P/E
15.15xvs Medical Devices peers
Price to Sales (TTM)
4.36xvs Medical Devices peers
Price to Book (MRQ)
1.48xvs Medical Devices peers
Enterprise to Revenue
3.67xvs Medical Devices peers
Gross Margin
63.24%vs Medical Devices peers
Profit Margin
-8.98%vs Medical Devices peers
Operating Margin
17.24%vs Medical Devices peers
Return on Assets (TTM)
-2.11%vs Medical Devices peers
Return on Equity (TTM)
-3.04%vs Medical Devices peers
Revenue (TTM)
1.87BCNY277.48M · vs all stocks (USD)
Revenue per Share (TTM)
3.89CNYUpdated Aug 19, 2026Quarterly Revenue Growth
-27.30%vs Medical Devices peers
Gross Profit (TTM)
1.01BCNY150.30M · vs all stocks (USD)
EBITDA (TTM)
190.61MCNY28.31M · vs all stocks (USD)
Net Income (TTM)
-167.76MCNY-24.92M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-55.40%vs Medical Devices peers
Operating Cash Flow (TTM)
830.00MCNY123.27M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
153.86MCNY22.85M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.2200CNYUpdated Aug 19, 2026Trailing Annual Dividend Yield
1.30%vs all stocks
5-Year Average Dividend Yield
1.50%vs all stocks
Payout Ratio
72.73%vs Medical Devices peers
Minority Interest (Equity)
58.93MCNYFY2025 · Dec 31, 2025Revenue
2.09BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
897.85MCNYFY2025 · Dec 31, 2025Gross Profit
1.19BCNYFY2025 · Dec 31, 2025Operating Income
-97.80MCNY-14.52M · vs all stocks (USD)
Pre-tax Income
-114.69MCNYFY2025 · Dec 31, 2025Income Tax Expense
-45.03MCNYFY2025 · Dec 31, 2025Net Income
-69.66MCNYFY2025 · Dec 31, 2025EBIT
-83.55MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
190.61MCNYFY2025 · Dec 31, 2025Research & Development
336.70MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
425.97MCNYFY2025 · Dec 31, 2025Other Operating Expenses
15.02MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
7.67MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
31.14MCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.1300CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.1300CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
484.81MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
484.81MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-69.66MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
6.63MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
252.18MCNYFY2025 · Dec 31, 2025Free Cash Flow
-51.92MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
462.00MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-69.66MCNYFY2025 · Dec 31, 2025Other Non-cash Items
30.67MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
271.58MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
19.58MCNYFY2025 · Dec 31, 2025Capital Expenditures
-304.10MCNYFY2025 · Dec 31, 2025Net Acquisitions
1.01MCNYFY2025 · Dec 31, 2025Purchase of Investments
-4.77BCNYFY2025 · Dec 31, 2025Sale of Investments
4.66BCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-417.46MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-197.64MCNYFY2025 · Dec 31, 2025Other Financing Charges
-209.77MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-407.40MCNYFY2025 · Dec 31, 2025Shares Outstanding
468.09MSharesUpdated Aug 19, 2026Float Shares
258.63MSharesUpdated Aug 19, 2026% Held by Insiders
46.57%vs all stocks
% Held by Institutions
4.95%vs all stocks
Total Cash (MRQ)
1.97BCNY292.75M · vs all stocks (USD)
Total Cash per Share (MRQ)
4.20CNYUpdated Aug 19, 2026Total Debt (MRQ)
607.48MCNY90.22M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.1089xvs Medical Devices peers
Current Ratio (MRQ)
3.22xvs Medical Devices peers
Book Value per Share (MRQ)
11.77CNYUpdated Aug 19, 2026Total Assets
6.60BCNY980.48M · vs all stocks (USD)
Total Current Assets
3.30BCNYFY2025 · Dec 31, 2025Total Liabilities
1.13BCNYFY2025 · Dec 31, 2025Total Non-current Assets
3.30BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
89.24MCNYFY2025 · Dec 31, 2025Total Current Liabilities
1.04BCNYFY2025 · Dec 31, 2025Cash
460.33MCNYFY2025 · Dec 31, 2025Cash Equivalents
2.19MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
462.53MCNYFY2025 · Dec 31, 2025Other Short-term Investments
1.26BCNYFY2025 · Dec 31, 2025Accounts Receivable
774.19MCNYFY2025 · Dec 31, 2025Inventory
280.58MCNYFY2025 · Dec 31, 2025Accounts Payable
210.81MCNYFY2025 · Dec 31, 2025Short-term Debt
592.39MCNYFY2025 · Dec 31, 2025Other Current Liabilities
29.75MCNYFY2025 · Dec 31, 2025Long-term Debt
9.26MCNYFY2025 · Dec 31, 2025Common Stock (Book)
468.08MCNYFY2025 · Dec 31, 2025Retained Earnings
3.30BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
5.47BCNY812.93M · vs all stocks (USD)
Treasury Stock
30.09MCNYFY2025 · Dec 31, 202552-Week Low
15.47CNYUpdated Aug 19, 202652-Week High
26.29CNYUpdated Aug 19, 202652-Week Change
-26.25%vs all stocks
Beta
0.8280xvs all stocks
50-Day MA
17.65CNYUpdated Aug 19, 2026200-Day MA
19.25CNYUpdated Aug 19, 2026Avg 10-Day Volume
6.48MSharesUpdated Aug 19, 2026Avg 30-Day Volume
7.79MSharesUpdated Aug 19, 2026Diluted EPS (TTM)
-0.3400CNYUpdated Aug 19, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.63Profit Margin: -0.09
Financial Health
Altman Z-Score 5.61: safe zoneNotable
Altman Z-Score: 5.61
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Scale
Market cap is $1.18B, above the global median of $1.15BNotable
Market cap (USD): 1,179,763,807.506Global Median: 1,146,734,693.424
Levered free cash flow is $22.85M, above the global median of $16.24MNotable
Levered free cash flow (USD): 22,851,662.659Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Sunflower Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
QuidelOrtho Corporation
Tier 1ProductionApproval-Gated PipelineRule
0009K0
Tier 1ProductionApproval-Gated PipelineRuleRisk
Zhejiang Garden Bio-chemical High-tech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Tandem Diabetes Care Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Collegium Pharmaceutical Inc.
Tier 1ProductionApproval-Gated PipelineRule
Avanos Medical Inc.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Glass House Brands Inc.
Tier 1ProductionApproval-Gated PipelineFlowRule
Guilin Sanjin Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Northeast Pharmaceutical Group Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow